Key Highlights
- Daryl Todd joins Kalderos as Chief Strategy Officer.
- Former Assistant General Counsel at Johnson & Johnson.
- Expert in compliance, commercial contracting, and regulatory law.
- Aims to innovate drug discount management solutions.
- Kalderos identified over $1 billion in inaccurate discount requests.
Source: PR Newswire
Notable Quotes
- “Daryl’s experience with hospitals and drug manufacturers, besides his meaningful work with patients and doctors, gives us valuable insights into 340B, Medicaid, and commercial drug discount programs designed to lower the price of drugs for consumers.” — Angie Franks, CEO at Kalderos
- “Kalderos is well-positioned to navigate the changes and challenges impacting the drug discount ecosystem today.” — Daryl Todd, Chief Strategy Officer at Kalderos
SoHC's Take
The appointment of Daryl Todd as Chief Strategy Officer at Kalderos marks a significant strategic move for the company. With Todd’s extensive background in regulatory law and experience in the pharmaceutical industry, particularly his tenure at Johnson & Johnson, Kalderos is poised to enhance its leadership in drug discount management solutions. Todd’s track record of developing patient-focused programs and structuring collaborative arrangements will be invaluable as Kalderos seeks to innovate and address the growing complexities of drug discount and rebate programs. His expertise will undoubtedly contribute to Kalderos’ mission of simplifying compliance, building trust among stakeholders, and ensuring accurate reimbursement of discounts and rebates.
